Search Results - "TERCEL, Moana"

Refine Results
  1. 1

    Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action by Choi, Peter Jaein, Tomek, Petr, Tercel, Moana, Reynisson, Jóhannes, Park, Thomas In Hyeup, Cooper, Elizabeth Alexandra, Denny, William Alexander, Jose, Jiney, Leung, Euphemia

    Published in Molecules (Basel, Switzerland) (27-01-2022)
    “…The CDK4/6 inhibitor palbociclib, combined with endocrine therapy, has been shown to be effective in postmenopausal women with estrogen receptor-positive,…”
    Get full text
    Journal Article
  2. 2

    Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models by Lee, Tet Woo, Singleton, Dean C., Harms, Julia K., Lu, Man, McManaway, Sarah P., Lai, Amy, Tercel, Moana, Pruijn, Frederik B., Macann, Andrew M. J., Hunter, Francis W., Wilson, William R., Jamieson, Stephen M. F.

    Published in Molecular oncology (01-08-2024)
    “…Tumour hypoxia promotes poor patient outcomes, with particularly strong evidence for head and neck squamous cell carcinoma (HNSCC). To effectively target…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System by Sharrock, Abigail V, McManaway, Sarah P, Rich, Michelle H, Mumm, Jeff S, Hermans, Ian F, Tercel, Moana, Pruijn, Frederik B, Ackerley, David F

    Published in Frontiers in pharmacology (07-06-2021)
    “…Bacterial nitroreductase enzymes that can efficiently convert nitroaromatic prodrugs to a cytotoxic form have numerous applications in targeted cellular…”
    Get full text
    Journal Article
  5. 5

    Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylators by Wilson, William R, Stribbling, Stephen M, Pruijn, Frederik B, Syddall, Sophie P, Patterson, Adam V, Liyanage, H D Sarath, Smith, Eileen, Botting, K Jane, Tercel, Moana

    Published in Molecular cancer therapeutics (01-10-2009)
    “…Hypoxia represents an important therapeutic target in tumors because of the resistance of hypoxic cells to radiotherapy and chemotherapy and because it is more…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Optimised synthesis of a nitroCBI hypoxia-activated prodrug with substantial anticancer activity by Lee, Ho H., Dickson, Benjamin D., Stevenson, Ralph J., Yang, Shangjin, Tercel, Moana

    Published in Tetrahedron (31-05-2019)
    “…An optimised synthesis of a hypoxia-activated anticancer prodrug related to the duocarmycin family of natural products is described. The improved 10-step…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Hypoxia-Selective Antitumor Agents. 12. Nitrobenzyl Quaternary Salts as Bioreductive Prodrugs of the Alkylating Agent Mechlorethamine by Tercel, Moana, Wilson, William R, Anderson, Robert F, Denny, William A

    Published in Journal of medicinal chemistry (01-03-1996)
    “…A series of benzene-substituted analogues of the novel hypoxia-selective cytotoxin N,N-bis(2-chloroethyl)-N-methyl-N-(2-nitrobenzyl)ammonium chloride (3a),…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Nitro seco Analogues of the Duocarmycins Containing Sulfonate Leaving Groups as Hypoxia-Activated Prodrugs for Cancer Therapy by Stevenson, Ralph J, Denny, William A, Tercel, Moana, Pruijn, Frederik B, Ashoorzadeh, Amir

    Published in Journal of medicinal chemistry (22-03-2012)
    “…The synthesis of 19 (5-nitro-2,3-dihydro-1H-benzo[e]indol-1-yl)methyl sulfonate prodrugs containing sulfonate leaving groups and 7-substituted…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The Cytotoxicity of Duocarmycin Analogues is Mediated through Alkylation of DNA, not Aldehyde Dehydrogenase 1: A Comment by Tercel, Moana, McManaway, Sarah P., Leung, Euphemia, Liyanage, H. D. Sarath, Lu, Guo-Liang, Pruijn, Frederik B.

    Published in Angewandte Chemie International Edition (17-05-2013)
    “…The answer lies in the DNA: Recent claims that the alkylation of a particular protein contributes to the cytotoxicity of the duocarmycins could not be…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Selective Treatment of Hypoxic Tumor Cells In Vivo: Phosphate Pre-Prodrugs of Nitro Analogues of the Duocarmycins by Tercel, Moana, Atwell, Graham J, Yang, Shangjin, Ashoorzadeh, Amir, Stevenson, Ralph J, Botting, K. Jane, Gu, Yongchuan, Mehta, Sunali Y, Denny, William A, Wilson, William R, Pruijn, Frederik B

    Published in Angewandte Chemie (International ed.) (07-03-2011)
    “…Hitting the hypoxic target: Combining a nitro prodrug with a water‐soluble phosphate converts duocarmycin analogues from highly toxic DNA‐alkylating agents to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    A new enantioselective approach to the core structure of hypoxia selective prodrugs related to the duocarmycins by Heinrich, Daniel M., Youte, Jean-Jacques, Denny, William A., Tercel, Moana

    Published in Tetrahedron letters (21-12-2011)
    “…The indoline scaffold of hypoxia selective prodrugs of DNA-alkylating agents related to the duocarmycin natural products was synthesized via an…”
    Get full text
    Journal Article